AtriCure investor relations material

AtriCure, Inc. develops, is a global company that manufactures and sells devices for the surgical ablation of cardiac tissue and systems to medical centers worldwide. It offers Isolator Synergy Ablation System for the treatment of atrial fibrillation, Isolator Synergy Access Ablation System that is used during an open surgical procedure, AtriClip LAA exclusion device that is designed to prevent stroke and AtriClip PRO that allows physicians to avoid potential complications from stitches in the heart. The company also provides EnSite Precision Cardiac Mapping System, which enables surgeons to create detailed three-dimensional models of a patient's heart during surgery.